Finished Research Projects

ARCoV-005

A Global, Multi-center, Randomized, Double-Blind, Placebo-controlled, Phase III Clinical Study to Evaluate the Protective Efficacy, Safety and Immunogenicity of SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine in Population Aged 18 Years and Older

Proxalutamide

A Randomized, Double-blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects

hzVSF-v13

hzVSF-v13_0007 trial is a multicenter phase 2 randomized control trial to evaluate the efficacy and safety of a novel anti-vimentin monoclonal antibody for moderate to severe COVID-19 patients.

Truncate-TB Study

Two-Month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-Sensitive Tuberculosis

A Phase II clinical trial evaluating the efficacy and safety of BDB-001, an investigational recombinant humanized IgG4 monoclonal antibody, for the treatment of severe and progressive COVID-19. The study explores BDB-001 as a targeted immunomodulatory therapy aimed at improving clinical outcomes in hospitalized patients.

AVIMAC

A Randomized, Open label, Controlled Study to Evaluate Efficacy and Tolerability of the Administration of AVIMAC as Adjuvant Treatment in Mild or Moderate COVID-19 Patients who Receive the Standard Treatment

BDB-001

Monovalent
BA 4/5 Fase 1,2/3

A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS- CoV-2 Variant (BA.4/5) mRNA Vaccine (ABO1020) in Healthy Subjects Aged 18 Years and Older Who Have Completed the Full Vaccination

A Randomized, Double-Blind, and Placebo-Controlled Phase 1 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant mRNA Vaccines (ABO1009-DP and ABO-CoV.617.2) in Indonesian Subjects Aged 18 Years and Older Who Have Not Received SARS-CoV-2 Vaccines

Monovalent Phase-1